Paeds SAQs · paediatric-dermatology
Petechiae, purpura and vasculitic rashes — formative SAQs
Formative SAQs on petechiae, purpura and vasculitic rashes in children: the triage and emergency management of a febrile child with a rapidly progressive petechial rash (the sick-versus-well split, the glass test, first-hour antibiotics and resuscitation, purpura fulminans and the ISTH disseminated intravascular coagulation score), and the assessment and management of a well child with newly diagnosed immune thrombocytopenia including the differentiation from leukaemia and the ASH 2019 risk-based approach.
On this page
Study tools
Target exams
SAQ 1 (10 marks)
A 14-month-old girl is brought to the emergency department with a six-hour history of fever, irritability and a rash. On examination she is flushed but cool peripherally, with a capillary refill of four seconds, a heart rate of 170 beats per minute and a blood pressure of 78/40 mmHg. A petechial rash over the lower limbs is spreading onto the trunk, with two enlarging dark purpuric patches on the thigh. Her initial full blood count shows a platelet count of 45 × 10⁹ per litre, a prolonged prothrombin time, a low fibrinogen and a markedly raised D-dimer. [8] [9]
Question: Outline your immediate assessment and triage, the emergency management over the first hour, the interpretation of the blood results, and the disposition and public-health actions. (10 marks) [8]
Model answer
Immediate assessment and triage (2 marks). This is a sick child with a rapidly progressive non-blanching rash and signs of septic shock — meningococcal septicaemia with purpura fulminans until proven otherwise. The first split is sick versus well, and this child is unwell: tachycardia, hypotension, prolonged capillary refill and a spreading petechial rash confirm the emergency pathway. Confirm the rash is non-blanching with the glass test, but do not delay treatment to classify it further. [8]
Emergency management over the first hour (3 marks). Give high-flow oxygen, establish intravenous or intraosseous access, take blood cultures and a full blood count, film, coagulation, lactate and blood gas, and give a broad-spectrum parenteral antibiotic such as ceftriaxone within the first hour. Administer a 10 to 20 mL per kilogram crystalloid bolus for shock, reassess and repeat with escalation to intensive care for refractory shock. Antibiotic delay is the preventable cause of death, so the antibiotic comes before the cultures return. [8] [9]
Interpretation of the blood results (3 marks). The platelet count of 45 × 10⁹ per litre, the prolonged prothrombin time, the low fibrinogen and the markedly raised D-dimer indicate disseminated intravascular coagulation driving the purpura fulminans. Apply the ISTH overt disseminated intravascular coagulation score — platelet count, fibrin markers such as D-dimer, prothrombin time and fibrinogen — to grade it. Manage the coagulopathy with haematology-guided fresh-frozen plasma, platelets and, in selected inherited cases, protein C concentrate, alongside treating the sepsis. [9]
Disposition and public-health actions (2 marks). Admit to paediatric intensive care or retrieve to a tertiary centre for ongoing resuscitation, blood-product support and, once stable, surgical and burn-unit care for necrotic skin. Notify public health promptly for contact identification and chemoprophylaxis of close contacts, and arrange vaccination review. The diagnosis is clinical and the management has already begun. [8] [9]
References5ShowHide
- [1]Provan D; Arnold DM; Bussel JB; et al Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv, 2019.PMID 31770441
- [2]Neunert C; Terrell DR; Arnold DM; et al American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv, 2019.PMID 31794604
- [3]Rodeghiero F; Stasi R; Gernsheimer T; et al Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 2009.PMID 19005182
- [8]Sabra A; Benger J Meningococcal disease in children: a clinical review. Turk J Pediatr, 2011.PMID 22272447
- [9]Taylor FB Jr; Toh CH; Hoots WK; et al Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost, 2001.PMID 11816725